We're excited to see @PCI Pharma Services continue to strengthen its capabilities in support of assembly for the BD Libertas™ Wearable Injector, marking an important step toward validated assembly readiness in 2026. Learn more #BDemployee https://t.co/yICJDkrU5y
BD is pleased to announce that Ludovic Gil, PhD, R&D Manager at BD Pharmaceutical Systems, will be co-presenting a Tech Talk with Thomas James of SHL Medical at @PODD 2026. Oct 29 - 3:00 PM – 3:15 PM - Track 1A - Sheraton Boston, Massachusetts #BDemployee https://t.co/BUXwWCf5Wr
🎉 Congratulations to @Natasha Bolick of BD and @Robert Gresham of Gilead Sciences! Their podium presentation was selected as one of three finalists for the PDA Drug Delivery Partnership Innovation Award. #BDemployee https://t.co/SwMHqWWTiB
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/ds37yqFGBd
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/9aYz1E89I7
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/oXpdECRxuJ
Join BD is heading at PODD 2026 on October 29–30. Join us at booth #530. At BD, collaboration plays an important role in advancing drug delivery technologies, and PODD is an opportunity to connect, share insights, and explore new opportunities. #BDemployee https://t.co/Qj8ioEIB6U
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/RyBTENLHYg
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/FOgPDCamGQ
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/PLsfLf9g8L
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/58ikXP8x1X
From 19–21 October, the BD team will be attending the event and looking forward to connecting with customers, partners and industry colleagues. 🤝 Will you be there? We’d love to connect and exchange ideas. #BDemployee https://t.co/VlGtItxA2I
Thanks for connecting with us at CPHI Milan 2026! It was a great opportunity to meet with you, exchange ideas, and discuss the future of injectable biologics. Let's keep the conversation going and continue exploring what's next in drug delivery #BDemployee https://t.co/fBiKUTCnJV
🙏 Thank you to everyone who visited BD at booth #515, attended our podium presentations, explored our scientific posters, and connected with our teams during the PDA Conference 2026. Let’s keep the conversation going. #BDemployee https://t.co/SqnSoi8s0U
Grand River Aseptic Manufacturing & BD announce fill-finish services supporting BD Libertas™ Wearable Injector Through this strategic alliance, we have successfully established 5 mL and 10 mL cartridge fill-finish capability for BD Libertas™ #BDemployee https://t.co/DHP7LbZRYD
How can dual-injection functionality be integrated into established prefillable syringe and autoinjector platforms? Collaborative testing with Ypsomed AG and SHL Medical evaluated integration, dose accuracy, ... [Read More] #BDemployee https://t.co/R3zPHzfW5d
The article explores complementary approaches including silicone emulsion spiking, interfacial tension, quartz crystal microbalance, high silicone container testing, water contact angle, extraction and quantification, imaging and force testing. #BDemployee https://t.co/528vnP4wYe
Meet Thomas Brun, ZebraSci, at CPHI Milan 2026. Booth #11D17 | Hall 11 | Oct. 6-8 From feasibility study and design verification testing, ZebraSci supports combination product programs across the drug delivery journey. #BDemployee https://t.co/IhznaMeLBL
In a new Parenteral Technology Supplement article, ZebraSci experts Alex Downs & Vincent Laperle explore how silicone sensitivity, migration, surface behaviour & device functional performance can be characterised during combination product dvpt #BDemployee https://t.co/w30bestjuJ
Join the Trace the Future: BD iDFill™ RFID Integration Tour @CPHI Milan 2026. In just 60 minutes, you’ll discover how unit-level identification using RFID technology can be implemented across the sterile manufacturing process #BDemployee https://t.co/XPm63kc7Ke